Literature DB >> 10877456

Epidemiology and pathogenesis of influenza.

M C Zambon1.   

Abstract

Influenza A, B and C all have a segmented genome, although only certain influenza A subtypes and influenza B cause severe disease in humans. The two major proteins of influenza are the surface glycoproteins-haemagglutinin (HA) and neuraminidase (NA). HA is the major antigen for neutralizing antibodies and is involved in the binding of virus particles to receptors on host cells. Pandemics are a result of novel virus subtypes of influenza A, created by reassortment of the segmented genome (antigenic shift), whereas annual epidemics are a result of evolution of the surface antigens of influenza A and B virus (antigenic drift). The rapid evolution of influenza viruses highlights the importance of surveillance in identifying novel circulating strains. Infectivity of influenza depends on the cleavage of HA by specific host proteases, whereas NA is involved in the release of progeny virions from the cell surface and prevents clumping of newly formed virus. In birds, the natural hosts of influenza, the virus causes gastrointestinal infection and is transmitted via the faeco-oral route. Virulent avian influenza strains, which cause systemic disease, have an HA that is cleaved by proteases present in all cells of the body, rather than by proteases restricted to the intestinal tract. In mammals, replication of influenza subtypes appears restricted to respiratory epithelial cells. Most symptoms and complications, therefore, involve the respiratory tract. However, systemic complications are sometimes observed and other viral genes besides the HA, including the NA, may be involved in determination of virulence of influenza strains in mammals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10877456     DOI: 10.1093/jac/44.suppl_2.3

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  69 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

Review 2.  Patterns of antigenic diversity and the mechanisms that maintain them.

Authors:  Marc Lipsitch; Justin J O'Hagan
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

Review 3.  The evolution of seasonal influenza viruses.

Authors:  Velislava N Petrova; Colin A Russell
Journal:  Nat Rev Microbiol       Date:  2017-10-30       Impact factor: 60.633

4.  Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR.

Authors:  J Li; S Chen; D H Evans
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Molecular epidemiology and phylogenetic analysis of HA gene of influenza A(H1N1)pdm09 strain during 2010-2014 in Dalian, North China.

Authors:  Yan Han; Nan Sun; Qiu-Yue Lv; Dan-Hong Liu; Da-Peng Liu
Journal:  Virus Genes       Date:  2016-06-01       Impact factor: 2.332

6.  Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.

Authors:  Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Limited Tryptic Digestion-Isotope Dilution Mass Spectrometry (LTD-IDMS): A Reagent-Free Analytical Assay To Quantify Hemagglutinin of A(H5N1) Vaccine Material.

Authors:  Hans C Cooper; Yuhong Xie; Giuseppe Palladino; John R Barr; Ethan C Settembre; Yingxia Wen; Tracie L Williams
Journal:  Anal Chem       Date:  2020-08-12       Impact factor: 6.986

8.  5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.

Authors:  Priya Ranjan; Lakshmi Jayashankar; Varough Deyde; Hui Zeng; William G Davis; Melissa B Pearce; John B Bowzard; Mary A Hoelscher; Victoria Jeisy-Scott; Mayim E Wiens; Shivaprakash Gangappa; Larisa Gubareva; Adolfo García-Sastre; Jacqueline M Katz; Terrence M Tumpey; Takashi Fujita; Suryaprakash Sambhara
Journal:  Virol J       Date:  2010-05-21       Impact factor: 4.099

Review 9.  Recent Advances in Development of DNA Vaccines Against Hepatitis C virus.

Authors:  Sami Ullah; Muhammad Ali A Shah; Nosheen Riaz
Journal:  Indian J Virol       Date:  2012-03-20

10.  Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005.

Authors:  Ivo M Foppa; Md Monir Hossain
Journal:  Emerg Themes Epidemiol       Date:  2008-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.